Gemfibrozil, stretching arms beyond lipid lowering.

Area of Science:

• Pharmacology
• Molecular Biology
• Immunology

Background:

• Gemfibrozil is a well-established lipid-lowering agent.
• Its primary use is in managing hyperlipidemia by reducing triglyceride levels.

Purpose of the Study:

• To review the multifaceted biological activities of gemfibrozil beyond its lipid-lowering effects.
• To explore the underlying mechanisms of gemfibrozil's diverse actions.
• To assess the potential of gemfibrozil as a therapeutic agent for various human disorders.

Main Methods:

• Literature review of recent studies on gemfibrozil.
• Analysis of signaling pathways regulated by gemfibrozil.
• Synthesis of evidence on gemfibrozil's effects on inflammation, immune cells, and oxidative stress.

Main Results:

• Gemfibrozil demonstrates significant lipid-lowering effects, reducing triglycerides and hyperlipidemia risk.
• Beyond lipid regulation, gemfibrozil modulates inflammatory pathways.
• Gemfibrozil influences T-helper cell switching, cell-to-cell contact, migration, and oxidative stress.

Conclusions:

• Gemfibrozil possesses a broader range of biological activities than previously recognized.
• These pleiotropic effects involve the regulation of key cellular signaling pathways.
• Gemfibrozil holds promise as a primary or adjunct therapy for diverse human conditions.